A novel therapy with zoledronic acid od bone metastasis in advanced prostate cancer reflecting molecular investigations
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 1
Abstract
Prostate cancer continues to represent a major therapeutic challenge. There is still observed a large number of patients worldwide. This malignancy is mainly diagnosed in industrialized countries. Dietary factors, lifestyle – related factors, and androgens have long been recognized as contributors to the risk of prostate cancer. During the last 10 years, molecular studies have provided unexpected molecular events showing the prostate cancer tumorigenesis and progression. The modern therapy of prostate cancer relies on hormonal therapy. One step further for treatment of androgen-independent prostate cancer means chemotherapy based upon docetaxel, estramustine, and glucocorticoids. Bone metastases are frequent in prostate cancer. One of the drawbacks of long-term hormone therapy has been reported in recent studies as the changed bone metabolism. Long-term treatment of zoledronic acid is safe and gives substantial clinical benefits for men with metastatic hormone-refractory prostate cancer. The huge challenge still exists to seek novel agents which will offer better results in the course of the entity. Imatinib is a well-known agent blocking the function of protein kinases, and one of them is associated with PDGF (platelet-derived growth factor) receptor. The latter could become a target in the treatment of prostate cancer. Vitamin D and its metabolites may improve results of chemotherapy used to control prostate cancer.
Authors and Affiliations
Gabriel Wcisło, Sylwia Oborska, Lubomir Bodnar, Katarzyna Szarlej-Wcisło, Cezary Szczylik
Keywords
Related Articles
- EP ID EP83626
- DOI -
- Views 72
- Downloads 0
Extreme hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)in a patient with a small cell lung cancer - a case report and literature review
Introduction: A case of symptomatic SIADH syndrome with an extremely low sodium level occurring at the beginning of the treatment course in a patient with small cell lung cancer is described. Case report: A 64-year-old...
Zalecenia diagnostyczno-terapeutyczne dla wybranych nowotworów głowy i szyi. Rak jamy ustnej i wargi
The clinical significance of p21WAF1/CIP1 protein expression in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the most common human malignancy in the majority of the developed countries. Prognosis in this tumor has virtually not changed during the last decades and still remains particularly...
Radioterapia w leczeniu zaawansowanego raka jelita grubego
Ocena skuteczności różnych metod radioterapii przerzutów raka płuca do mózgu
Rak płuca jest najczęściej spotykanym nowotworem złośliwym u mężczyzn – powoduje ok. 1/3 zachorowań i zgonów. Wśród kobiet rak płuca jest drugim co do częstotliwości występowania po raku piersi. Przerzuty do ośrodkowego...